740 related articles for article (PubMed ID: 31221723)
1. Evolution of prodromal parkinsonian features in a cohort of
Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
[TBL] [Abstract][Full Text] [Related]
2. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
Beavan M; McNeill A; Proukakis C; Hughes DA; Mehta A; Schapira AH
JAMA Neurol; 2015 Feb; 72(2):201-8. PubMed ID: 25506732
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the frequency of non-motor symptoms of Parkinson's disease in adult patients with Gaucher disease type 1.
Wilke MVMB; Dornelles AD; Schuh AS; Vairo FP; Basgalupp SP; Siebert M; Nalin T; Piltcher OB; Schwartz IVD
Orphanet J Rare Dis; 2019 May; 14(1):103. PubMed ID: 31077260
[TBL] [Abstract][Full Text] [Related]
4. Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
Mullin S; Beavan M; Bestwick J; McNeill A; Proukakis C; Cox T; Hughes D; Mehta A; Zetterberg H; Schapira AHV
Mov Disord; 2019 Sep; 34(9):1365-1373. PubMed ID: 31251436
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk.
Becker-Cohen M; Zimran A; Dinur T; Tiomkin M; Cozma C; Rolfs A; Arkadir D; Shulman E; Manor O; Paltiel O; Yahalom G; Berg D; Revel-Vilk S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293067
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.
Thaler A; Bregman N; Gurevich T; Shiner T; Dror Y; Zmira O; Gan-Or Z; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A
Parkinsonism Relat Disord; 2018 Oct; 55():45-49. PubMed ID: 29784561
[TBL] [Abstract][Full Text] [Related]
7. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
[TBL] [Abstract][Full Text] [Related]
8. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S; Louis E; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Payami H; Molho E; Factor S; Ottman R; Clark LN; Marder K
Neurology; 2012 May; 78(18):1434-40. PubMed ID: 22442429
[TBL] [Abstract][Full Text] [Related]
9. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric characteristics of GBA-associated Parkinson disease.
Swan M; Doan N; Ortega RA; Barrett M; Nichols W; Ozelius L; Soto-Valencia J; Boschung S; Deik A; Sarva H; Cabassa J; Johannes B; Raymond D; Marder K; Giladi N; Miravite J; Severt W; Sachdev R; Shanker V; Bressman S; Saunders-Pullman R
J Neurol Sci; 2016 Nov; 370():63-69. PubMed ID: 27772789
[TBL] [Abstract][Full Text] [Related]
11. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
12. Predictors of the Rapid Progression in Prodromal Parkinson's Disease: A Longitudinal Follow-Up Study.
Liu P; Chen L; He X; Mao L
Gerontology; 2024; 70(6):595-602. PubMed ID: 38565088
[TBL] [Abstract][Full Text] [Related]
13. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.
Barber TR; Lawton M; Rolinski M; Evetts S; Baig F; Ruffmann C; Gornall A; Klein JC; Lo C; Dennis G; Bandmann O; Quinnell T; Zaiwalla Z; Ben-Shlomo Y; Hu MTM
Sleep; 2017 Aug; 40(8):. PubMed ID: 28472425
[TBL] [Abstract][Full Text] [Related]
14. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
[TBL] [Abstract][Full Text] [Related]
15. Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease.
Arkadir D; Dinur T; Becker Cohen M; Revel-Vilk S; Tiomkin M; Brüggemann N; Cozma C; Rolfs A; Zimran A
Eur J Neurol; 2019 Jul; 26(7):1013-1018. PubMed ID: 30714262
[TBL] [Abstract][Full Text] [Related]
16. Features of
Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
[TBL] [Abstract][Full Text] [Related]
17. Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.
Gatto EM; Etcheverry JL; Sanguinetti A; Cesarini M; Fernandez Escobar N; Drelichman G
Eur Neurol; 2016; 76(1-2):19-21. PubMed ID: 27344356
[TBL] [Abstract][Full Text] [Related]
18. Glucocerebrosidase Mutations and Motor Reserve in Parkinson's Disease.
Chung SJ; Lee PH; Sohn YH; Kim YJ
J Parkinsons Dis; 2021; 11(4):1715-1724. PubMed ID: 34459414
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Alcalay RN; Wolf P; Chiang MSR; Helesicova K; Zhang XK; Merchant K; Hutten SJ; Scherzer C; Caspell-Garcia C; Blauwendraat C; Foroud T; Nudelman K; Gan-Or Z; Simuni T; Chahine LM; Levy O; Zheng D; Li G; Sardi SP;
Ann Clin Transl Neurol; 2020 Oct; 7(10):1816-1830. PubMed ID: 32888397
[TBL] [Abstract][Full Text] [Related]
20. Hyposmia and cognitive impairment in Gaucher disease patients and carriers.
McNeill A; Duran R; Proukakis C; Bras J; Hughes D; Mehta A; Hardy J; Wood NW; Schapira AH
Mov Disord; 2012 Apr; 27(4):526-32. PubMed ID: 22344629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
